CYCCP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cyclacel Pharmaceuticals (CYCCP) Ownership - Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

200 Connell Drive

Phone

+1 908 517-7330

Employees

Web

https://cyclacel.com

Details

Group

Domestic Stock Funds

Fundamentals

CYCCP

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

1.35

Dividend Yield

0.02

Total Cash

2.98M

Total Cash/Share

N/A

Total Debt

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

74K

ROE

N/A

Book Value

-970K

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

0.77

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-15.47M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-150.81

Shares Held By Institutions

1.3K

Shares Outstanding - Current

N/A

Total Liabilities

6.35M

Total Volume MTD

N/A

Value

Gain YTD

-36.900

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CYCCP (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of mechanism-targeted drugs to treat human cancers

Industry Biotechnology